Both the RGDS and GFOGER peptides are known to bind integrin β1 (ITGB1), which is associated with proliferation and metastasis of breast cancer cells and a poor prognosis in patients.49–51,57. This evidence concerns the gene ITGB1 and breast carcinoma.